Business · 08/08/2023Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on QTc Information in Human Prescription Drug Labeling
Summary
The FDA has released a draft guidance to help pharmaceutical companies accurately include information on QTc interval prolongation in the labeling of their prescription drugs and biological products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →